Beta Bionics (BBNX) Price to Book (2025 - 2026)
Beta Bionics' (BBNX) quarterly Price to Book came in at 2.75 in Q2 2026, up 31.04% year-over-year from 2.1 in Q2 2025, and up 67.02% quarter-over-quarter from 1.65 in Q1 2026.
Analysis
Beta Bionics (BBNX) Price to Book (2025 - 2026) Analysis & Trends
Beta Bionics has disclosed Price to Book across 2 years of filings, most recently posting 2.75 for Q2 2026.
- In Q2 2026, Price to Book rose 31.04% year-over-year to 2.75; the TTM figure through Jun 2026 stood at 2.75 (up 31.04% YoY), while the FY2025 annual figure was 4.7, changed N/A from the prior year.
- Price to Book came in at 2.75 for Q2 2026 at Beta Bionics, up from 1.65 in the prior quarter.
- In the past five years, Price to Book ranged from a high of 4.7 in Q4 2025 to a low of 1.2 in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn |
| 10 | Beta Bionics | 873.54 Mn | 693.05 Mn | 18.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.75 |
| Mar 31, 2026 | 1.65 |
| Dec 31, 2025 | 4.70 |
| Sep 30, 2025 | 2.97 |
| Jun 30, 2025 | 2.10 |
| Mar 31, 2025 | 1.20 |